US Patent 7928073 Purified polypeptides having IL-13 receptor activity
Patent 7928073 was granted and assigned to Sanofi on April, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+204 characters)
Article
Patent abstract
This invention relates to a purified polypeptide comprising an amino acid sequence chosen from the sequence SEQ ID NO:4 or biologically active amino acid sequences derived from SEQ ID NO:4.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Daniel Caput0
Natalio Vita0
Pascual Ferrara0
Patrick Laurent0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07928073 Purified polypeptides having IL-13 receptor activity US Patent 7928073 Purified polypeptides having IL-13 receptor activity
Infobox
Patent Number
079280730
Patent Number
79280730
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079280730
Date of Patent
April 19, 2011
0Patent Application Number
111823840
Date Filed
July 15, 2005
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07928073 Purified polypeptides having IL-13 receptor activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07928073
Date of patent
April 19, 2011
Patent application number
11182384
Date Filed
July 15, 2005
Patent primary examiner
Find more entities like US Patent 7928073 Purified polypeptides having IL-13 receptor activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
